Biotech Law
Glaxo to Pay $3 Billion for Human Genome – Businessweek
That compares with the median of 7.9 times sales in a survey of more than 50 similar biotechnology deals over the past … start a bidding war,” said Erik Gordon, a professor of law and business at the University of … Continue reading
ZIOPHARM Oncology Announces New Executive Team – msnbc.com
Belbel, Executive Vice President, Chief Legal Officer and Secretary … competition from pharmaceutical and biotechnology companies; the development of and our ability to take advantage of the market for DNA-based biotherapeutics; our ability …
Building a Legacy for the Next 50: WASITRAC organizes US-India Trade Summit in Seattle, September 27-28, 2012 – YAHOO!
(Doctorate of Law) by the Berhampur University in India … chemicals & pharmaceuticals, life sciences, biotechnology, nanotechnology, automobiles, shipbuilding, tourism and convention. The summit will also have a special session on corporate social …
Phoenix Nest — a Virtual Biotech — Announces Its Launch in the Wake of New Law Signed by President Obama on July 9th – msnbc.com
Phoenix Nest announces the launch of its virtual biotech, with plans to take advantage of the new legislation enacted by Congress and signed into law on July 9, 2012, The Food and Drug Administration Safety and Innovation Act (FDASIA), S. … Continue reading
Phoenix Nest — a Virtual Biotech — Announces Its Launch in the Wake of New – PR Inside
NEW YORK, NY — (Marketwire) — 07/16/12 — Phoenix Nest announces the launch of its virtual biotech, with plans to take advantage of the new legislation enacted by Congress and signed into law on July 9, 2012, The Food and … Continue reading
Phoenix Nest — a Virtual Biotech — Announces Its Launch in the Wake of New Law Signed by President Obama on July 9th – NBCNews.com
Phoenix Nest announces the launch of its virtual biotech, with plans to take advantage of the new legislation enacted by Congress and signed into law on July 9, 2012, The Food and Drug Administration Safety and Innovation Act (FDASIA), S. … Continue reading
Hatteras Venture Partners invests in N.Y. biotech – Worldnews.com
! style=”background:#f0f8ff; color:#000; height:16px;” maxmin ! style=”background:#f0f8ff; color:#000; height:16px;” maxmin ! style=”background:#f0f8ff; color:#000; height:16px;” maxmin ! style=”background:#f0f8ff; color:#000; height:16px …
GSK TO ACQUIRE HUMAN GENOME SCIENCES FOR US$14.25 PER SHARE IN CASH – FierceBiotech
Lazard and Morgan Stanley are acting as financial advisors to GSK, and Cleary Gottlieb Steen & Hamilton and Wachtell, Lipton, Rosen & Katz are providing legal advice to the company. Goldman, Sachs & Co. and Credit Suisse Securities (USA) LLC … Continue reading
Geniuses or Dabblers? Tech CEOs Who Win Their Own Patents – Forbes
A handful of biotech CEOs are able to stay active as inventors, too, says Vern Norviel, head of the patents and innovation counseling practice at Wilson Sonsini Goodrich & Rosati, a leading Silicon Valley law firm. It’s harder, though …
Dyadic Demonstrates Industry-leading Biofuels Enzyme Performance – Yahoo Finance
About Dyadic Dyadic International, Inc. is a global biotechnology company that uses its patented … Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.